James Kuo
Fondateur chez TRYPTAMINE THERAPEUTICS LIMITED
Fortune : 312 447 $ au 30/04/2024
Profil
James S.
Kuo was the founder of Windtree Therapeutics, Inc. (founded in 1992) and BioMicro Systems, Inc. (founded in 2003), where he held the titles of President & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He is also the founder of Tryp Therapeutics, Inc. (founded in 2019) and currently serves as a Director.
Dr. Kuo is also the founder of Monarch Labs, Inc. Dr. Kuo's current jobs include Chairman & Chief Executive Officer at ApoLife, Inc. (since 2012), Chief Executive Officer at Return Health, Inc., Non-Executive Chairman at MSK Pharma LLC, Independent Director at Pharnext SA (starting in 2022), Managing Director at Athena Bioventures, Inc. (since 2007), and Vice President-Research & Development at Silo Pharma, Inc. (starting in 2022).
His former jobs include Chief Executive Officer & IR Contact at FIT Biotech Oy (2016-2018), Chairman & Chief Executive Officer at Cysteine Pharma, Inc. (2006-2007), Chief Executive Officer at OncoTracker, Inc. (2018-2019), Chairman & Chief Executive Officer at KMRB Acquisition Corp.
II, Non-Executive Chairman at Soligenix, Inc. (2004-2009), Chairman at ImmunoPrecise Antibodies Ltd.
(2016-2023), Associate Director-Corporate Licensing at Pfizer Inc. (1995-1997), Managing Director-Venture Analysis at HealthCare Ventures LLC, Director at Cordex Pharma, Inc. (2007-2010), Director at Theriva Biologics, Inc. (2007-2012), and Vice President-Business Development at Myriad Genetics, Inc. (1998-2000).
Dr. Kuo's education includes an undergraduate degree from Haverford College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the University of Pennsylvania Medical Center.
Dr. Kuo is also the founder of Monarch Labs, Inc...
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TRYP THERAPEUTICS, INC.
6,22% | 09/01/2024 | 6 000 000 ( 6,22% ) | 282 000 $ | 30/04/2024 |
| 17/03/2023 | 25 500 ( 0,10% ) | 30 447 $ | 30/04/2024 |
Postes actifs de James Kuo
| Sociétés | Poste | Début |
|---|---|---|
| TRYPTAMINE THERAPEUTICS LIMITED | Fondateur | - |
| PHARNEXT SCA | Directeur/Membre du Conseil | 16/06/2022 |
| SILO PHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/09/2022 |
Return Health, Inc.
 Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | Directeur Général | - |
Athena Bioventures, Inc
 Athena Bioventures, Inc Financial ConglomeratesFinance Athena Bioventures, Inc provides investment services. The private company is based in La Jolla, CA. The CEO of the company is Geraldine Kuo. | Corporate Officer/Principal | 01/01/2007 |
ApoLife, Inc.
 ApoLife, Inc. Miscellaneous Commercial ServicesCommercial Services ApoLife, Inc. provides screening and lab services. James S. Kuo has been the CEO of the American company since 2012. | Directeur Général | 27/09/2012 |
| MSK Pharma LLC | Président | 11/04/2011 |
Monarch Labs, Inc.
 Monarch Labs, Inc. Industrial SpecialtiesProcess Industries Part of Veeco Instruments, Inc., Monarch Labs, Inc. develops and manufactures automated quasi-static test systems for the data storage industry. The company is based in Longmont, CO. Monarch Labs was acquired by Veeco Instruments, Inc. on January 31, 2000 for $15.80 million. The company was founded by James S. Kuo. | Fondateur | - |
Anciens postes connus de James Kuo
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Président | 09/11/2023 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de James Kuo
| Haverford College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| University of Pennsylvania Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| MYRIAD GENETICS, INC. | Health Technology |
| SILO PHARMA, INC. | Health Technology |
| THERIVA BIOLOGICS, INC. | Health Technology |
| PHARNEXT SCA | Health Technology |
| IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
| Entreprise privées | 13 |
|---|---|
BioMicro Systems, Inc.
 BioMicro Systems, Inc. BiotechnologyHealth Technology BioMicro® Systems, Inc. is a private company founded in 2000 with expertise in micro fluidics. BioMicro Systems is focused on the development and commercialization of biological research products based on its proprietary micro fluidic handling technologies. The BioMicro Systems, Inc. mission is to apply its expertise in creating novel technologies to address customer requirements for improved data quality, throughput and laboratory effectiveness. They will build a superior organization to enhance the value of BioMicro Systems to its customers, employees, partners, and shareholders. BioMicro Systems, Inc. was founded in 2000 and is based in Salt Lake City, Utah. BioMicro Systems is a private company that serves the life sciences community by developing and marketing biological research products based on its proprietary micro fluidic and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. BioMicro Systems has recently expanded its product portfolio to include the all-new MAUI Wash System and Kreatech labeling kits. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results. | Health Technology |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Finance |
FIT Biotech Oy
 FIT Biotech Oy BiotechnologyHealth Technology FIT Biotech Oy engages in the business of researching, developing, and manufacturing diagnostic laboratory tests and pharmaceutical products. The firm is also involved in marketing gene transport unit vector technology to be used as a gene transport mechanism in gene therapeutic applications. The company was founded on May 17, 1995 and is headquartered in Tampere, Finland. | Health Technology |
Monarch Labs, Inc.
Monarch Labs, Inc. Industrial SpecialtiesProcess Industries Part of Veeco Instruments, Inc., Monarch Labs, Inc. develops and manufactures automated quasi-static test systems for the data storage industry. The company is based in Longmont, CO. Monarch Labs was acquired by Veeco Instruments, Inc. on January 31, 2000 for $15.80 million. The company was founded by James S. Kuo. | Process Industries |
Cordex Pharma, Inc.
 Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
ApoLife, Inc.
ApoLife, Inc. Miscellaneous Commercial ServicesCommercial Services ApoLife, Inc. provides screening and lab services. James S. Kuo has been the CEO of the American company since 2012. | Commercial Services |
| Cysteine Pharma, Inc. | |
| MSK Pharma LLC | |
KMRB Acquisition Corp. II
 KMRB Acquisition Corp. II Financial ConglomeratesFinance KMRB Acquisition Corp. II is a developmented stage company, which will engaged in warrants, financial instruments, and acquisition of companies. The company was founded on August 17, 2015 and was headquartered in Seminole, FL. | Finance |
Athena Bioventures, Inc
Athena Bioventures, Inc Financial ConglomeratesFinance Athena Bioventures, Inc provides investment services. The private company is based in La Jolla, CA. The CEO of the company is Geraldine Kuo. | Finance |
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada. | Health Technology |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | Health Technology |
OncoTracker, Inc.
 OncoTracker, Inc. Pharmaceuticals: MajorHealth Technology OncoTracker, Inc. is a medical diagnostics company focusing on immuno-oncology. The firm involves research and drug discovery in hematological cancers. It provides therapies, sBCMA testing, and testing and services. The company was founded by James R Berenson in 2014 and is headquartered in West Hollywood, CA. | Health Technology |
